World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 4436850

Number of visits today: 4250

Number of downloads: 4069485

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Liu C, Xu X, Yuan H, Zhang Y, Zhang Y, Song S, Yang Z. Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer. Front Oncol 2020;10:580277. [PMID: 33251143 DOI: 10.3389/fonc.2020.580277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]

For:

Liu C, Xu X, Yuan H, Zhang Y, Zhang Y, Song S, Yang Z. Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer. Front Oncol 2020;10:580277. [PMID: 33251143 DOI: 10.3389/fonc.2020.580277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]

Number	Citing Articles
1	Ulaner GA, Mankoff DA, Clark AS, Fowler AM, Linden HM, Peterson LM, Dehdashti F, Kurland BF, Mortimer J, Mouabbi J, Moon DH, de Vries EGE. Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-(18)F-Fluoro-17β-Fluoroestradiol. J Nucl Med 2023;64:351-4. [PMID: 36863779 DOI: 10.2967/jnumed.123.265420] [Reference Citation Analysis]
2	Liu C, Hu S, Xu X, Zhang Y, Wang B, Song S, Yang Z. Evaluation of tumour heterogeneity by ¹⁸F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment. Breast Cancer Res 2022;24:57. [PMID: 36028895 DOI: 10.1186/s13058-022-01555-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3	Yadav D, Kumar R, Phulia A, Basu S, Alavi A. Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers. PET Clin 2022;17:399-413. [PMID: 35717099 DOI: 10.1016/j.cpet.2022.04.001] [Reference Citation Analysis]
4	Piccardo A, Fiz F, Treglia G, Bottoni G, Trimboli P. Head-to-Head Comparison between ¹⁸F-FES PET/CT and ¹⁸F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:1919. [PMID: 35407526 DOI: 10.3390/jcm11071919] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5	Hao W, Li Y, Du B, Li X. Heterogeneity of estrogen receptor based on 18F-FES PET imaging in breast cancer patients. Clin Transl Imaging 2021;9:599-607. [DOI: 10.1007/s40336-021-00456-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]